glp-1 agonist pregnancy Receptor Agonists in - What Physicians Need to Know? AJOG Expert Review: Glucagon-like peptide-1
Description
Require step therapy or exclude others entirely
Liraglutide for weight management: a critical review of the evidence
This distinction matters enormously when evaluating tirzepatide risk because the FDA warning specifically concerns C-cell tumors, not the far more common follicular or papillary thyroid cancers
A meta-analysis of 76 RCTs has recently found that compared with placebo or active controls, GLP-1RA treatment was associated with an increased risk of gallbladder or biliary diseases (RR, 1.37
GLP-1 receptor agonist-associated tumor adverse events: A real-world study from 2004 to 2021 based on FAERS
